Essex Woodlands Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-49,687	Closed	-$3.28M	–	10
2017 Q1	$3.28M	Sell	49,687 -3,040	-6%	-$201K	0.75%	8
2016 Q4	$2.42M	Hold	52,727	–	–	0.55%	8
2016 Q3	$2.4M	Hold	52,727	–	–	0.5%	9
2016 Q2	$3.92M	Buy	+52,727	New	+$3.92M	0.99%	8